Helix Acquisition Corp. III priced its IPO of 15 million shares at $10 each, targeting healthcare investments.
Quiver AI Summary
Helix Acquisition Corp. III announced the pricing of its initial public offering of 15 million Class A ordinary shares at $10.00 per share, which will begin trading on The Nasdaq Global Market under the ticker symbol "HLXC" starting today, January 23, 2026. The public offering is expected to close on January 26, 2026. The company, a special purpose acquisition entity focused on healthcare and related industries, is sponsored by Helix Holdings III LLC and managed by CEO Bihua Chen and CFO Caleb Tripp. Leerink Partners and Oppenheimer & Co. are co-managing the offering, which includes an option for underwriters to purchase an additional 2.25 million shares. The release also includes a standard disclaimer about the forward-looking nature of the statements contained.
Potential Positives
- Helix Acquisition Corp. III successfully priced its upsized initial public offering of 15,000,000 Class A ordinary shares at $10.00 per share, indicating strong investor interest.
- The shares will be listed on The Nasdaq Global Market under the ticker symbol “HLXC,” enhancing the company's visibility and market presence.
- The offering includes a 45-day option for underwriters to purchase an additional 2,250,000 shares, which could lead to increased capital and financial flexibility for the company.
Potential Negatives
- The initial public offering may raise concerns about the company's ability to successfully identify and execute a business combination, as it is a special purpose acquisition company (SPAC) without any established business at the time of the offering.
- The inclusion of forward-looking statements indicates significant uncertainty surrounding the completion of the offering and the intended use of proceeds, which may signal potential risks to investors.
- The press release lacks details on specific business combinations being pursued, which could lead to skepticism about the company's strategy and future prospects.
FAQ
What is Helix Acquisition Corp. III's initial public offering price?
Helix Acquisition Corp. III priced its initial public offering at $10.00 per share.
When will Helix Acquisition Corp. III shares start trading?
The shares will begin trading on The Nasdaq Global Market under the ticker symbol “HLXC” starting January 23, 2026.
What is the purpose of Helix Acquisition Corp. III?
The Company aims to effect a merger or similar business combination, focusing on healthcare industries.
How many shares did Helix Acquisition Corp. III offer?
The Company announced an upsized offering of 15,000,000 Class A ordinary shares.
Who are the joint bookrunning managers for the offering?
Leerink Partners and Oppenheimer & Co. are serving as the joint bookrunning managers for Helix Acquisition Corp. III's offering.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
Full Release
January 23, 2026
BOSTON, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Helix Acquisition Corp. III (the “Company”) announced today that it priced its upsized initial public offering of 15,000,000 Class A ordinary shares at $10.00 per share. The shares will be listed on The Nasdaq Global Market and trade under the ticker symbol “HLXC” beginning today. The Company expects the offering to be consummated on January 26, 2026.
The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on opportunities in healthcare or healthcare-related industries. The Company, sponsored by Helix Holdings III LLC, an affiliate of Cormorant Asset Management, is led by Bihua Chen as Chief Executive Officer and Chairperson, and Caleb Tripp as Chief Financial Officer and Chief Operating Officer.
Leerink Partners and Oppenheimer & Co. are serving as the joint bookrunning managers for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 2,250,000 Class A ordinary shares at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.
The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from: Leerink Partners LLC, Attn: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, or by telephone at (800) 808-7525 ext. 6105, or by email at [email protected] ; and Oppenheimer & Co. Inc. Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, or by telephone at (212) 667-8055, or by email at [email protected] .
A registration statement relating to these securities became effective on January 22, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Forward-Looking Statements
This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the Company's offering filed with the Securities and Exchange Commission (the “SEC”). Copies are available on the SEC's website, www.sec.gov . The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Investor and Media Contact
Helix Acquisition Corp. III
Caleb Tripp
Email:
[email protected]
Telephone: (857) 702-0370
